You are here: Industry Insights > Novo Nordisk

News List

Novo Nordisk's new online chatbot, available 24/7 for diabetes questions fiercepharma
September 19, 2018
Say hello to Sophia, Novo Nordisk's new online chatbot, available 24/7 for diabetes questions
Novo Nordisk stockpiles 16 weeks' worth of insulin in preparation for hard Brexit pharmafile
September 13, 2018
Danish multinational Novo Nordisk has announced that they are increasing their stocks of insulin products to ensure that there are 16 weeks’ worth of supplies, in preparation for a hard no deal Brexit.
Novo Nordisk invests in glucose binding tech to stay ahead in diabetes market pharmaceutical-technology
September 04, 2018
On 17 August Novo Nordisk announced the complete acquisition of Ziylo, a University of Bristol spinout company, for $800 million.
Deals and M&As this week: Tolero Pharmaceuticals, BioNTech, Novo Nordisk pharmaceutical
August 27, 2018
Tolero Pharmaceuticals has entered a clinical research collaboration with AbbVie for the development of a therapy for acute myeloid leukaemia (AML).
Novo Nordisk adds to diabetes pipeline with Evotec deal fiercebiotech
August 24, 2018
Novo Nordisk has signed another deal intended to keep it at the top of the tree when it comes to developing new diabetes and obesity drugs.
Novo Nordisk inks deal with Evotec to develop small-molecule drugs for diabetes, obesity firstwordpharma
August 23, 2018
Novo Nordisk entered a strategic alliance with Evotec to develop small-molecule therapies to treat patients with diabetes and obesity, the German company said Wednesday.
Evotec, Novo Nordisk Enter Strategic Diabetes Alliance contractpharma
August 23, 2018
Evotec AG has entered a strategic alliance with Novo Nordisk to discover and develop novel small molecule therapies to treat diabetes and obesity, as well as co-morbidities such as nonalcoholic steatohepatitis (NASH), cardiovascular diseases, and diabetic
Novo Nordisk acquires Ziylo Ltd to accelerate its development of glucose responsive insulins worldpharmanews
August 20, 2018
Ziylo and Novo Nordisk A/S today announced that Novo Nordisk has acquired all of the shares of Ziylo, a University of Bristol spin-out company based at Unit DX science incubator in Bristol, UK
Novo Nordisk sees revenues drop in Q2 pharmatimes
August 09, 2018
Novo Nordisk saw revenues drop 4% in the second quarter as the diabetes segment stumbled, but reported solid performance for some of its key brands.
Novo Nordisk channels '70s 'Magic' in first TV ad for blockbuster-in-waiting Ozempic fiercepharma
August 02, 2018
Novo Nordisk debuted its first DTC campaign for Type 2 diabetes drug Ozempic this week, setting the promotional stage for its aspiring blockbuster.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 13 14 Next page